Evolving Natural History of Metastatic Prostate Cancer

Introduction The systemic therapies available to patients with metastatic prostate cancer (mPC) have improved dramatically over the past decade. Anecdotal experience suggests that the increased available lines of therapy have changed the profile of mPC to include a higher prevalence of visceral meta...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cureus
Glavni autori: Nafissi, Nellie N, Kosiorek, Heidi E, Butterfield, Richard J, Moore, Cassandra, Ho, Thai, Singh, Parminder, Bryce, Alan H
Format: Artigo
Jezik:Inglês
Izdano: Cureus 2020
Teme:
Internal Medicine
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7735525/
https://ncbi.nlm.nih.gov/pubmed/33329980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.11484
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items